Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza

Archives of Internal Medicine

Volumn 161, Issue 5, 2001, Pages 749-759

  Nichol, K L ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ABSENTEEISM; ARTICLE; CLINICAL TRIAL; COST BENEFIT ANALYSIS; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DRUG COST; GUILLAIN BARRE SYNDROME; HEALTH CARE COST; HUMAN; INFLUENZA; MORTALITY; PRIORITY JOURNAL; VACCINATION;

EID: 0035848356     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.161.5.749     Document Type: Article

References (55)

1. Advances in influenza virus vaccine research
2. Excess pneumonia and influenza associated hospitalizations during influenza epidemics in the United States, 1970-78
3. Impact of influenza epidemics on mortality in the United States from October 1972 to May 1985
4. Serious morbidity and mortality associated with influenza epidemics
5. Immunization policies and vaccine coverage among adults: The risk for missed opportunities
6. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
7. Influenza vaccination
8. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community
9. A perspective on the significance of pandemic influenza
10. The effectiveness of vaccination against influenza in healthy, working adults
11. Effectiveness and cost-benefit of influenza vaccination of healthy working adult: A randomized controlled trial
12. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza
13. Zanamivir in the prevention of influenza among healthy adults: A randomized controlled trial
14. Effective protection against influenza after vaccination with subunit vaccine
15. Impact of epidemics upon communities and families
16. Emerging infections: Pandemic influenza
17. Prevention and early treatment of influenza in healthy adults
18. Influenza: Quantifying morbidity and mortality
19. Survey of underlying conditions of persons hospitalized with acute respiratory disease during influenza epidemics in Houston, 1978-1981
20. Influenza-associated morbidity and mortality in young and middle-aged women
21. Influenza: Its control in persons and populations
22. Excess pneumonia-influenza mortality by age and sex in three major influenza A2 epidemics, United States, 1957-58, 1960 and 1963
23. The impact of influenza on mortality in the USA
24. The impact of influenza and influenza-like illness on productivity and healthcare resource utilization in a working population
25. Influenza vaccination among healthy employees: A cost- benefit analysis
26. Effect of influenza B virus infection on human performance
27. Side effects associated with influenza vaccination in healthy working adults: A randomized, placebo-controlled trial
28. The Guillain-Barre syndrome and the 1992-1993 and 1993-1994 influenza vaccines
29. Control of influenza
30. Viral respiratory disease at Lowry Air Force Base in Denver, 1952-1982
31. Prevention of influenza virus infections by current inactivated influenza virus vaccines
32. A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease
33. Influenza, pneumococcal, and hepatitis B immunization
34. The economic impact of pandemic influenza in the United States: Priorities for intervention
35. Cost-effectiveness analysis
36. Appendix I: Productivity losses tables
37. Recommendations for reporting cost-effectiveness analyses
38. Probabilistic sensitivity analysis using Monte Carlo simulation: A practical approach
39. The impact of influenza epidemics on hospitalizations
40. Vaccination against influenza: Five-year study in the Post Office
41. Sickness absence following a campaign of vaccination against influenza in the workplace
42. Cost-effectiveness of the influenza vaccine in a healthy, working-age population
43. Cost-effectiveness analysis of a rotavirus immunization program for the United States
44. Cost-effectiveness of a routine varicella vaccination program for US children
45. Updated recommendations from the Advisory Committee on Immunization Practices in response to delays in supply of influenza vaccine for the 2000-01 season
46. Prevention and control of influenza: Recommendations of the Advisory Committee on Immunization Practices
47. Lowering the age for routine influenza vaccination to 50 years: AAFP leads the nation in influenza vaccine policy